AstraZeneca has admitted for the first time in court documents that its Covid vaccine (Covishield) can cause rare side effects, marking an about-turn that may open the door for a multi-million pound legal payout
AstraZeneca admits its Covishield vaccine may lead to rare side effect
AstraZeneca has acknowledged for the first time in court documents that its Covid-19 vaccine, marketed globally under brand names such as Covishield and Vaxzevria, among others, may result in a rare side effect. Media reports indicate that this admission was made in a legal document submitted to the UK High Court in February.
In the document, the company acknowledged that a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS) can occur even without vaccination. It stated that expert testimony would be necessary to establish causation in each individual case. The document further admitted, “It is acknowledged that the AZ vaccine can, in very rare instances, lead to TTS. However, the causal mechanism is not fully understood.”
The vaccine, developed in partnership with the University of Oxford, was produced in India by the Pune-based Serum Institute of India (SII). As of 10:30 pm on April 29, 2024, a total of 1,749,417,978 doses of the Covishield vaccine have been administered in India. This marks the world’s largest vaccination campaign, which commenced in January 2021, as per data from the government’s CoWIN vaccine dashboard.
The British-Swedish multinational pharmaceutical and biotechnology company, headquartered in Cambridge, is currently facing a class-action lawsuit. The lawsuit alleges that its vaccine resulted in severe injuries and fatalities.
Multiple media reports have detailed complaints filed by several families in court, alleging that the side effects of the AstraZeneca vaccine have caused severe and devastating impacts. The lawsuit was initiated last year by Jamie Scott, a father of two, who endured a permanent brain injury as a result of Thrombosis with Thrombocytopenia Syndrome (TTS) following his administration of the AstraZeneca vaccine in April 2021.
Scott’s case, along with many others’, reveals the severe impact of TTS, which leads to blood clots and low platelet counts.
Speaking to The Telegraph Scott’s wife Kate said, “The medical world has acknowledged for a long time that vaccine-induced immune thrombocytopenia and thrombosis (VITT) was caused by the vaccine.”
Kate has demanded an apology, fair compensation for their family and other families who have been affected.
AstraZeneca’s admission is seen as a key moment in the ongoing legal dispute, underscoring potential risks linked to vaccination.
एस्ट्राजेनेका कोविड वैक्सीन ग्लोबल स्तर पर कोविशील्ड और वैक्सजेवरिया ब्रांड नामों के तहत बेची गई
— News24 (@news24tvchannel) April 29, 2024
◆ यूके मीडिया की एक रिपोर्ट के मुताबिक
◆ एस्ट्राजेनेका ने यूके HC में दिए गए अपने अदालती दस्तावेजों में पहली बार माना
◆ TTS सिंड्रोम शरीर में खून के थक्के जमने की वजह बनती है… pic.twitter.com/zZ0QZyOeS0